Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
News Bird & Bird advises MOL on joint acquisition of Scotland's Port of Nigg

Sep 11 2025

Read More
News Bird & Bird hires industrials, infrastructure and transport expert Eleanor Kerslake as new partner

Sep 08 2025

Read More
Deal Bird & Bird advises Siloco on the acquisition of NOVOCONT and NOVORENT

Sep 05 2025

Read More
Deal Bird & Bird advises Investronic shareholders on Evolem's equity investment

Sep 03 2025

Read More
News Bird & Bird strengthens Polish Energy & Utilities team with new partner hire

Sep 02 2025

Read More
News Bird & Bird boosts regulatory team in Brussels with double partner hire

Sep 01 2025

Read More